PIRAMAL PHARMA
Back to Balance Sheet
|
PIRAMAL PHARMA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-145 Cr | ₹-157 Cr | ₹-130 Cr | ₹-105 Cr | ₹-22 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of PIRAMAL PHARMA ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-145 Cr |
| Mar2024 | ₹-157 Cr |
| Mar2023 | ₹-130 Cr |
| Mar2022 | ₹-105 Cr |
| Mar2021 | ₹-22 Cr |
How is Deferred Tax Assets / Liabilities of PIRAMAL PHARMA Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-145 Cr | Negative | |
| Mar2024 | ₹-157 Cr | Negative | |
| Mar2023 | ₹-130 Cr | Negative | |
| Mar2022 | ₹-105 Cr | Negative | |
| Mar2021 | ₹-22 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹22,078.0 Cr | 0.3% | 0.3% | -19.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹413,717.0 Cr | 0.4% | 2.6% | NA | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,830.0 Cr | -4.5% | 0.7% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,479.0 Cr | 5% | 4.1% | 37.2% | Stock Analytics | |
| CIPLA | ₹108,978.0 Cr | -0.5% | -3.4% | -6.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,905.0 Cr | 1.2% | 10.2% | 4.8% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | 0.3% |
0.3% |
-19.6% |
| SENSEX | -0.6% |
0.6% |
9.8% |
You may also like the below Video Courses